ClinicalTrials.gov record
Completed Phase 3 Interventional

A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)

ClinicalTrials.gov ID: NCT06269107

Public ClinicalTrials.gov record NCT06269107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 40-week Study Comparing the Efficacy and Safety of Once Weekly IcoSema and Daily Insulin Glargine 100 Units/mL in Participants With Type 2 Diabetes Inadequately Controlled on Oral Anti Diabetic Drugs COMBINE 4

Study identification

NCT ID
NCT06269107
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
485 participants

Conditions and interventions

Interventions

  • IcoSema Drug
  • Insulin glargine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 14, 2024
Primary completion
May 26, 2025
Completion
Jul 7, 2025
Last update posted
Apr 8, 2026

2024 – 2025

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
30
Facility City State ZIP Site status
Scripps Whittier Diabetes Inst La Jolla California 92037
First Valley Med Grp Lancaster Lancaster California 93534
Clinical Trials Research_Sacramento Lincoln California 95821
Desert Oasis Hlthcr Med Group Palm Springs California 91355
Desert Oasis Hlthcr Med Group Palm Springs California 92262
Northeast Research Institute Fleming Island Florida 32003
Clinical Research of Cent FL Winter Haven Florida 33880
Atlanta Diabetes Associates Atlanta Georgia 30318
Endo Res Solutions Inc Roswell Georgia 30076
Elite Clinical Trials Blackfoot Idaho 83221
Cedar-Crosse Research Center Chicago Illinois 60607
Endeavor Health Skokie Illinois 60077
Cotton-O'Neil Diab & Endo Ctr Topeka Kansas 66606
Methodist Phys. Clinic Omaha Nebraska 68114
Albuquerque Clin Trials, Inc. Albuquerque New Mexico 87102
AMC Community Endocrinology Albany New York 12203
Southgate Medical Group, LLP West Seneca New York 14224
Physician's East Endocrinology Greenville North Carolina 27834
Diab & Endo Assoc of Stark Co Canton Ohio 44718
Advanced Medical Research Maumee Ohio 43537
New Venture Medical Research Wadsworth Ohio 44281-9236
Holston Medical Group Kingsport Tennessee 37660
Amarillo Med Spec LLP Amarillo Texas 79106
Velocity Clinical Research- Cedar Park Austin Texas 78759
Velocity Clinical Res-Dallas Dallas Texas 75230
North Texas Endocrine Center Dallas Texas 75231
Diabetes and Thyroid Ctr of FW Fort Worth Texas 76132
Fmc Science, Llc Lampasas Texas 76550
Quality Research Inc San Antonio Texas 78209
Flourish Research San Antonio Texas 78229
Consano Clinical Research, LLC Shavano Park Texas 78231
Wade Family Medicine Bountiful Utah 84010
TPMG Clinical Research Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06269107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06269107 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →